Publications by authors named "Edith Swann"

Claim this Profile
I
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial.
Alex Luedtke, Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Edith Swann

iScience· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320.
Avi Kenny, Janine van Duijn, One Dintwe, Jack Heptinstall, Randy Burnham, Edith Swann

EBioMedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.
Nathaniel Erdmann, Wilton B Williams, Stephen R Walsh, Derek W Cain, Matthew Clark, Edith Swann

medRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern Africa.
Pamela Mda, Kathryn Mngadi, Bo Zhang, Randy Burnham, Michal Juraska, Edith Swann

Front Reprod Health· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.
Glenda E Gray, Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B Gilbert, Edith Swann

Lancet Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.
Avi Kenny, Janine van Duijn, One Dintwe, Jack Heptinstall, Randy Burnham, Edith Swann

EBioMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study.
Ivalda Macicame, Nilesh Bhatt, Edna Viegas, Adam Yates, Chiaka Nwoga, Edith Swann

BMC Public Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Craig A Magaret, Li Li, Allan C deCamp, Morgane Rolland, Michal Juraska, Edith Swann

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01.
Yunda Huang, Lily Zhang, Shelly Karuna, Philip Andrew, Michal Juraska, Edith Swann

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Craig Magaret, Li Li, Allan deCamp, Morgane Rolland, Michal Juraska, Edith Swann

Res Sq· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Edith Swann

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioural science: NIH workshop directions.
Tia Morton, Wairimu Chege, Edith Swann, Theresa E Senn, Naana Cleland

AIDS· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults.
Srilatha Edupuganti, Stephen C De Rosa, Marnie Elizaga, Yiwen Lu, Xue Han, Edith Swann

Vaccines (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust antibody and cellular responses induced by DNA-only vaccination for HIV.
Stephen C De Rosa, Srilatha Edupuganti, Yunda Huang, Xue Han, Marnie Elizaga, Edith Swann

JCI Insight· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.
Nadine G Rouphael, Cecilia Morgan, Shuying S Li, Ryan Jensen, Brittany Sanchez, Edith Swann

J Clin Invest· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.
Scott D Neidich, Youyi Fong, Shuying S Li, Daniel E Geraghty, Brian D Williamson, Edith M Swann

J Clin Invest· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.
Glenda E Gray, Ying Huang, Nicole Grunenberg, Fatima Laher, Surita Roux, Edith M Swann

Sci Transl Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Dan H Barouch, Frank L Tomaka, Frank Wegmann, Daniel J Stieh, Galit Alter, Edith Swann

Lancet· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.
Youyi Fong, Xiaoying Shen, Vicki C Ashley, Aaron Deal, Kelly E Seaton, Edith Swann

J Infect Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection.
Javier R Lama, Shelly T Karuna, Shannon P Grant, Edith M Swann, Carmela Ganoza

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.
Merlin L Robb, Leigh A Eller, Hannah Kibuuka, Kathleen Rono, Lucas Maganga, Edith Swann

N Engl J Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Lindsey R Baden, Etienne Karita, Gaudensia Mutua, Linda-Gail Bekker, Glenda Gray, Edith Swann

Ann Intern Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 907.
Marie M Deschamps, Barbara Metch, Cecilia A Morgan, Carmen D Zorilla, Yeycy Donastorg, Edith Swann

J Acquir Immune Defic Syndr· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis